These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37240071)

  • 21. Targeting butyrophilins for cancer immunotherapy.
    Rigau M; Uldrich AP; Behren A
    Trends Immunol; 2021 Aug; 42(8):670-680. PubMed ID: 34253468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune recognition of phosphoantigen-butyrophilin molecular complexes by γδ T cells.
    Uldrich AP; Rigau M; Godfrey DI
    Immunol Rev; 2020 Nov; 298(1):74-83. PubMed ID: 33017054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of BTN3A1 on CD14
    Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
    Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
    Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.
    Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M
    Front Immunol; 2018; 9():662. PubMed ID: 29670629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Immunity by Butyrophilins.
    Rhodes DA; Reith W; Trowsdale J
    Annu Rev Immunol; 2016 May; 34():151-72. PubMed ID: 26772212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
    Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
    J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of macaque BTN3A genes and transcripts in the extended MHC: conserved orthologs of human γδ T cell modulators.
    de Groot N; Groen R; Orie V; Bruijnesteijn J; de Groot NG; Doxiadis GGM; Bontrop RE
    Immunogenetics; 2019 Sep; 71(8-9):545-559. PubMed ID: 31384962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins.
    Kabelitz D; Lettau M; Janssen O
    F1000Res; 2017; 6():. PubMed ID: 28649364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
    Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
    Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
    Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
    J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations.
    Nerdal PT; Peters C; Oberg HH; Zlatev H; Lettau M; Quabius ES; Sousa S; Gonnermann D; Auriola S; Olive D; Määttä J; Janssen O; Kabelitz D
    J Immunol; 2016 Oct; 197(8):3059-3068. PubMed ID: 27619996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-Activity Relationships of Butyrophilin 3 Ligands.
    Wiemer AJ
    ChemMedChem; 2020 Jun; 15(12):1030-1039. PubMed ID: 32453919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression level of BTN3A1 on the surface of CD14
    Tomogane M; Omura M; Sano Y; Shimizu D; Toda Y; Hosogi S; Kimura S; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 588():47-54. PubMed ID: 34952469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.
    Vantourout P; Eum J; Conde Poole M; Hayday TS; Laing AG; Hussain K; Nuamah R; Kannambath S; Moisan J; Stoop A; Battaglia S; Servattalab R; Hsu J; Bayliffe A; Katragadda M; Hayday AC
    Sci Adv; 2023 Dec; 9(49):eadj6174. PubMed ID: 38055824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. γδ T Cells in the Tumor Microenvironment-Interactions With Other Immune Cells.
    Chan KF; Duarte JDG; Ostrouska S; Behren A
    Front Immunol; 2022; 13():894315. PubMed ID: 35880177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.